Funding
| Narayana, P.A. (Principal Investigator) | Automated MR Image Analysis in MS: Identification of a Surrogate | National Institutes of Health (NIH) | August 15, 2002 - July 31, 2007 | |
| Narayana, P.A., (Principal Investigator) | Magnetic Resonance of Spinal Cord Injury | National Institutes of Health (NIH) | April 1, 2002 - March 31, 2007 | |
| Narayana, P.A. (PI: J. Steinberg, M.D.) | Neural Correlates of Cognition Schizophrenia | National Institutes of Health (NIH) | May 1, 2002 - April 30, 2005 | |
| Narayana, P.A. (Principal Investigator) | High Field MR Scanner for Animal Studies | National Institutes of Health (NIH) | June 1, 2003 - May 31,2004 | |
| Narayana, P.A., (Principal Investigator) | Serial Magnetic Resonance in Multiple Sclerosis |
National Institutes of Health (NIH) |
April 1, 1997 - March 31, 2004 |
|
|
Narayana, P.A. (PI: Moeller, F.G.) |
Serotonin, Drug Use and MDMA Induced Deficits | National Institutes of Drug Abuse |
April 1, 2003 - March 31, 2006 |
PAST GRANT SUPPORT:
|
Narayana, P.A. (PI: Jerry S. Wolinsky, M.D.) Antibiotic Treatment Trial Directed Against C. Pneumoniae in MS National Multiple Sclerosis Society / National Institutes of Health (NIH) August 1, 2000 - July 31, 2003 |
Narayana, P.A. (Principal Investigator) The Role of Neovascularization in Spinal Cord Injury: A Multidisciplinary Approach UT Biomedical Imaging Center Seed Grant September 1, 2002 - August 31, 2003 |
Narayana, P.A. (Principal Investigator) Serial Magnetic Resonance in Multiple Sclerosis. National Institutes of Health (NIH) April 1, 1997 - March 31, 2003 |
|
Narayana, P.A. (PI: Jerry S. Wolinsky, M.D.)
Protocol 01-9004, Open label study to evaluate the safety of Copaxone® and to monitor the neurologic course of disease in multiple
sclerosis patients treated with Copaxone. MRI Analysis Center - Teva Marion Partners April 1, 1998 - February 5, 2003 |
Narayana, P.A. (Principal Investigator) Serial MRSI: Sub-study of Primary Progressive Multiple Sclerosis Teva Marion Partners March 1, 1999 – February 28, 2003 |
Narayana, P.A. (PI: Jerry S. Wolinsky, M.D.) CombiRx study of relapsing multiple sclerosis: MRI Analysis Center Biogen/Teva Marion Partners (TMP) October 1, 1998 - March 31, 2003 (Biogen) |
|
Narayana, P.A. (Principal Investigator) Magnetic Resonance of Spinal Cord Injury National Institutes of Health (NIH) July 1, 1996 - June 30, 2001 |
Narayana, P.A. (Principal Investigator) High Field MR Scanner for In Vivo Animal Studies National Institutes of Health April 1, 2000 - March 31, 2001 |
Narayana, P.A. (PI: Jerry S. Wolinsky, M.D.) Miscellar Paclitaxel for the treatment of secondary progressive multiple sclerosis Angiotech Pharmaceuticals July 21, 2000 - June 30, 2000 |
|
Narayana, P.A., (Principal Investigator). Serial Magnetic Resonance in Multiple Sclerosis. National Institutes of Health (NIH) April 1, 1999 - March 31, 2000 |
Narayana, P.A. (Principal Investigator). Magnetic Resonance of Spinal Cord Injury National Institutes of Health (NIH) July 1, 1999 - June 30, 2000. |
Narayana, P.A. (PI: Jerry Wolinsky, M.D.) Micellar Paclitaxel for the Treatment of Secondary Progressive Multiple Sclerosis MRI Analysis Center August 1, 1998 - July 31, 2000 |
|
Narayana, P.A. (PI: Jerry Wolinsky, M.D.) Copaxone Open Label Amendment # 1 MRI Analysis Center April 1, 1998 - February 5, 2000 |
Narayana, P.A. (Co-PI; Staley Brod, M.D., PI) Oral-IFN Biological Effects in Relapsing Multiple Sclerosis National Institutes of Health (NIH) April 1, 1997 - March 31, 1999 |
Narayana, P.A. (Co-PI; Ian Butler, M.D., PI) Cerebral Palsy: A Classification Based on Magnetic Resonance Techniques and Neuropsychology Shriners Hospital for Crippled Children January 1, 1996 - December 31, 1997 |
|
Narayana, P.A. (PI: Jerry Wolinsky, M.D.) Phase 2 Study of Hu23F2G Multidose in Acute Exacerbations of Multiple Sclerosis April 1, 1998 - March 31, 1999 |
Narayana, P.A. (PI: Jerry Wolinsky, M.D.) Copaxone April 1, 1998 - March 31, 1999 |
Narayana, P.A. (Jerry Wolinsky, M.D.) MRI Analysis Center for: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Roquinimex (Linomide) in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Pharmacia, Inc. August 1, 1995 - July 31, 1999 |
|
Narayana, P.A. (Principal Investigator) Magnetic Resonance of Spinal Cord Injury National Institute of Health (NIH). July 1, 1992 - June 30, 1996 |
Narayana, P.A., (Co-PI; P.I.: Ian J. Butler, M.D.) In vivo Magnetic Resonance Spectroscopic Studies in Diseased and Developing Muscle. Shriners Hospital for Crippled Children. January 1, 1994 - December 31, 1995 |
Narayana, P.A. (Principal Investi-gator). Development Of Advanced Magnetic Resonance Technology For The In vivo Evaluation of Neurologic Diseases. Texas Higher Education Coordinating Board - Advanced Research Program. November 2, 1991 - October 31, 1994. |
|
Narayana, P.A., (Co-Principal Investigator) (P.I.: Ian J. Butler) Cerebral Palsy: a Classification Based on Magnetic Resonance Techniques and Neuropsychol-ogy. Shriners Hospital for Crippled Children January 1, 1993 - December 31, 1994 |
Narayana, P.A., (Principal Investigator) Proton Magnetic Resonance Spectroscopy and Imaging of Multiple Sclerosis. National Multiple Sclerosis Society October 1, 1992 - March 1, 1993 |
Narayana, P.A., (Co-Principal Investigator) P.I.: John H. Harris, Jr., M.D., D.Sc. Magnetic Resonance Imaging of Acute Spinal Cord Trauma. National Institutes of Health (NIH) 1989-1992 |
|
Narayana, P.A., (Co-Principal Investigator, P.I.: Ian J.
Butler, M.D.) In Vivo Proton Magnetic Resonance Spectroscopic Studies in Diseased and Developing Muscles. Shriners Hospital for Crippled Children. January 1, 1990 - December 31, 1992. |
Narayana, P.A., (Principal Investigator) Proton Magnetic Resonance Spectroscopy and Imaging of Multiple Sclerosis. National Multiple Sclerosis Society. October 1, 1990 - September 30, 1992. |
Narayana, P.A., (Principal Investigator) In vivo Proton Magnetic Resonance spectroscopy of Muscles. Muscular Dystrophy Association July 1, 1990 - December 31, 1991. |
|
Narayana, P.A., (Principal Investigator) Effect of 10 + days of space flight on neuro-muscular skeletal functions after emergency egress performance II. MRI-MRS changes. National Aeronautics Space Administration (NASA) - May 1, 1990 - September 1991. |
Narayana, P.A., (Principal Investigator) In Vivo Proton MRS of Normal And Abnormal Muscles. Muscular Dystrophy Association (MDA). |
Narayana, P.A., (Principal Investigator) Design And Development Of An Actively Shielded Gradient Coil System For In Vivo Localized Magnetic Resonance Spectrosco-py Studies. BRSG Grant, University of Texas, Medical School |
|
Narayana, P.A., (Principal Investigator) MR Techniques For Localized Proton Spectroscopy. National Institute of Health (NIH). |
Narayana, P.A., (Principal Investigator). Localized T1 Measurements in NMR. National Institutes Of Health (NIH). |
Narayana, P.A., (Principal Investigator). NMR Studies Of Muscular Dystrophy. BRSG Grant, University of Texas, Medical School. 1984-1986. |
|
Narayana, P.A., (Principal Investigator) Development And Application Of High Resolution And High Sensitivity Methods In Light Scattering, Magnetic Reso-nance And Combined Techniques. University Grants Commission, New Delhi, India. 1978-1981. |
Narayana, P.A. (PI: Jerry Wolinsky, M.D.) A multinational, multicenter, double-blind, placebo controlled study to evaluate the efficacy, tolerability and safety of glatiramer acetate in primary progressive sclerosis patients. Teva Marion Partners October 2, 1998 - September 30, 2002 |